Silo Pharma Stock Probability of Future OTC Stock Price Finishing Over 0.85
| SILO Stock | USD 1.39 0.02 1.46% |
Silo |
Silo Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Silo Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Silo Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Silo Pharma is way too risky over 90 days horizon | |
| Silo Pharma may become a speculative penny stock | |
| Silo Pharma appears to be risky and price may revert if volatility continues | |
| Silo Pharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 72.1 K. Net Loss for the year was (3.63 M) with profit before overhead, payroll, taxes, and interest of 66.26 K. | |
| Silo Pharma currently holds about 8.85 M in cash with (3.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Silo Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Silo OTC Stock often depends not only on the future outlook of the current and potential Silo Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Silo Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.1 M | |
| Cash And Short Term Investments | 7.7 M |
Silo Pharma Technical Analysis
Silo Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Silo OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Silo Pharma. In general, you should focus on analyzing Silo OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Silo Pharma Predictive Forecast Models
Silo Pharma's time-series forecasting models is one of many Silo Pharma's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Silo Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Silo Pharma
Checking the ongoing alerts about Silo Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Silo Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Silo Pharma is way too risky over 90 days horizon | |
| Silo Pharma may become a speculative penny stock | |
| Silo Pharma appears to be risky and price may revert if volatility continues | |
| Silo Pharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 72.1 K. Net Loss for the year was (3.63 M) with profit before overhead, payroll, taxes, and interest of 66.26 K. | |
| Silo Pharma currently holds about 8.85 M in cash with (3.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Other Information on Investing in Silo OTC Stock
Silo Pharma financial ratios help investors to determine whether Silo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Silo with respect to the benefits of owning Silo Pharma security.